Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction
- PMID: 22476992
- PMCID: PMC3343422
- DOI: 10.3349/ymj.2012.53.3.501
Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction
Abstract
Purpose: To investigate the changes and correlations of the serum inflammation factors levels and left ventricular (LV) structure and function in patients with acute ST segment elevation myocardial infarction (STEMI).
Materials and methods: A prospective study was performed on 70 STEMI patients and 70 control subjects. Serum levels of interleukin-6 (IL-6), soluble CD40 ligand (sCD40L), metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were measured by sandwich enzyme-linked immunosorbent assay (ELISA), and cardiac structure and function were assessed by echocardiography at admission and 3-year follow-up.
Results: We found that the levels of serum IL-6, sCD40L and MMP-9 increased steadily among control subjects, remote myocardial infarction and acute STEMI patients, and the level of TIMP-1 elevated remarkly at 3-year follow-up visit in STEMI. The admission level of serum MMP-9 positively correlated with LV end-diastolic and end-diastole volume (r=0.294, p=0.022; r=0.269, p=0.036, respectively), and TIMP-1 positively correlated with E/A ratio (r=0.278, p=0.044) at 3-year follow-up.
Conclusion: The study indicates that admission levels of serum MMP-9 and TIMP-1 closely correlated with left ventricular structure and function, which may be involved in the process of post-infarction remodeling of myocardium.
Conflict of interest statement
The authors have no financial conflicts of interest.
Similar articles
-
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.Clin Cardiol. 2008 Sep;31(9):413-8. doi: 10.1002/clc.20254. Clin Cardiol. 2008. PMID: 18781600 Free PMC article.
-
Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction.Heart Vessels. 2009 Sep;24(5):329-34. doi: 10.1007/s00380-008-1128-8. Epub 2009 Sep 27. Heart Vessels. 2009. PMID: 19784814
-
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.Clin Cardiol. 2009 May;32(5):288. doi: 10.1002/clc.20464. Clin Cardiol. 2009. PMID: 19452490 Free PMC article. No abstract available.
-
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.Eur Heart J. 2008 Sep;29(17):2116-24. doi: 10.1093/eurheartj/ehn315. Epub 2008 Jul 8. Eur Heart J. 2008. PMID: 18614523 Free PMC article.
-
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.Cardiology. 2018;139(1):17-24. doi: 10.1159/000481684. Epub 2017 Nov 16. Cardiology. 2018. PMID: 29141241 Clinical Trial.
Cited by
-
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy.J Clin Med. 2021 Jul 1;10(13):2968. doi: 10.3390/jcm10132968. J Clin Med. 2021. PMID: 34279451 Free PMC article. Review.
-
Regulation mechanism of aquaporin 9 gene on inflammatory response and cardiac function in rats with myocardial infarction through extracellular signal-regulated kinase1/2 pathway.Heart Vessels. 2019 Dec;34(12):2041-2051. doi: 10.1007/s00380-019-01452-8. Epub 2019 Jun 19. Heart Vessels. 2019. PMID: 31218464
-
Adiponectin-resistin index and its strong association with acute coronary syndrome in South Indian men.Inflamm Res. 2014 Nov;63(11):961-8. doi: 10.1007/s00011-014-0771-z. Epub 2014 Sep 14. Inflamm Res. 2014. PMID: 25217005
-
Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation, iNOS and NF-κB/p38 pathway.Exp Ther Med. 2018 Feb;15(2):1742-1748. doi: 10.3892/etm.2017.5599. Epub 2017 Dec 5. Exp Ther Med. 2018. PMID: 29434760 Free PMC article.
-
Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.PLoS One. 2016 Nov 23;11(11):e0166845. doi: 10.1371/journal.pone.0166845. eCollection 2016. PLoS One. 2016. PMID: 27880844 Free PMC article.
References
-
- Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:115–126. - PubMed
-
- Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108:1395–1403. - PubMed
-
- Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, Adler Y, et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol. 2006;98:14–18. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous